-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological: Poster II

Symposia: Acute Lymphoblastic Leukemias: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Ibrahim Aldoss, MD1, Dongyun Yang, PhD2*, Michelle Afkhami, MD3*, Zhaohui Gu, PhD4, Sally Mokhtari, PhD5, Shilpa Shahani, MD6*, Vaibhav Agrawal, MD1, Hoda Pourhassan, MD1*, Paul B. Koller, MD1, Vanina Tomasian, MS3*, Milhan Telatar, PhD3*, Monzr M. Al Malki, MD1, Amandeep Salhotra, MD7, Haris Ali, MD1, Ahmed Aribi, MD1, Karamjeet S. Sandhu, MD1, Shukaib Arslan, MD1, Brian J Ball, MD8, Salman Otoukesh, MD1*, Idoroenyi Amanam, MD1, Andrew S. Artz, MD, MS9, Pamela S. Becker, MD, PhD10, Forrest M. Stewart, MD1*, Peter T. Curtin, MD1, Raju Pillai, MD3*, Eileen P. Smith, MD10, Guido Marcucci, MD1, Anthony S. Stein, MD1, Stephen J Forman, MD11, Ryotaro Nakamura, MD1 and Vinod A. Pullarkat, MD1*

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Department of Pathology, City of Hope National Medical Center, Duarte, CA
4Department of Computational and Quantitative Medicine, Beckman Research Institute of City of Hope, Duarte, CA
5Department of Clinical Translational Program Development, City of Hope National Medical Center, Duarte, CA
6Department of Pediatrics, City of Hope National Medical Center, Duarte, CA
7Department of Hematology and HCT, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
8Department of Hematology/HCT, City of Hope National Medical Center, Pasadena, CA
9Department of Hematology/HCT, City of Hope, Duarte, CA
10Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
11City of Hope National Medical Center, Duarte, CA

Marcos J.G. de Lima, MD1, Partow Kebriaei, MD2, Francesco Lanza, MD3*, Christina Cho, MD4, Gizelle Popradi, MD, FRCP5, Michael T Hemmer, MS6*, Mei-Jie Zhang, PhD6*, Fan Zhang, PhD7*, Richa Shah, PharmD8, Verna Welch, PhD, MPH9*, Saara Tikka, PhD10*, Erik Vandendries, MD, PhD11, Matthias Stelljes, MD12, David I. Marks, MBBS, PhD13 and Wael Saber, MD, MS6

1Blood and Marrow and Cellular Therapy Program, The Ohio State University, Columbus, OH
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Ospedale di Ravenna, Ravenna, Italy
4Memorial Sloan Kettering Cancer Center, New York, NY
5McGill University Health Centre, Montreal, QC, Canada
6Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
7Pfizer Inc, Shanghai, China
8Pfizer Inc., New York
9Pfizer Inc, New York, NY
10Pfizer Oy, Helsinki, Finland
11Pfizer Inc, Cambridge, MA
12Universitätsklinikum Münster, Münster, Germany
13University Hospitals Bristol NHS Trust, Bristol, United Kingdom

Jenneke E. van Atteveld, MD1*, Demi T.C. de Winter, MD1*, Vincent G. Pluimakers, MD1*, Marta Fiocco, Prof. PhD1,2,3*, Rutger A.J. Nievelstein, MD1,4*, Monique G.G. Hobbelink, MD4*, Leontien C.M. Kremer, PhD1,5,6*, Cécile M. Ronckers, PhD1*, Martha A. Grootenhuis, PhD1*, Heleen Maurice-Stam, PhD7*, Wim J.E. Tissing, MD1,8*, Andrica C.H. de Vries, MD1,9, Jacqueline J. Loonen, MD10*, Eline Van Dulmen-den Broeder, PhD5*, Helena J. van der Pal, MD1*, Saskia Pluijm, PhD1*, Margriet van der Heiden-van der Loo, PhD1,11*, Birgitta Versluys, MD1*, Marloes Louwerens, MD12*, Dorine Bresters, MD1,13*, Hanneke M. van Santen, MD1,14*, Imo Hoefer, MD15*, Sjoerd A.A. van den Berg, PhD16,17*, Jan H.J. Hoeijmakers, PhD1,18*, Sebastian J.C.M.M. Neggers, MD1,17* and Marry M. van den Heuvel-Eibrink, MD1,19

1Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
2Medical Statistics Section, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, Netherlands
3Mathematical Institute, Leiden University, Leiden, Netherlands
4Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands
5Department of Pediatric Oncology, Emma Children’s Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
6Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
7Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
8Deparment of Pediatric Oncology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
9Department of Pediatric Oncology, Sophia Children’s Hospital, Erasmus Medical Center, Rotterdam, Netherlands
10Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
11Dutch Childhood Oncology Group, Utrecht, Netherlands
12Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands
13Department of Pediatrics, Willem Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands
14Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands
15Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, Netherlands
16Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, Netherlands
17Department of Internal Medicine, section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands
18Oncode Institute and Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, Netherlands
19Division of Child Health, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands

Melissa A Richard, PhD1,2*, Rachel M Harris, PhD2*, Philip J. Lupo, Ph.D., M.P.H.1,2*, Austin L Brown, MPH, PhD1,2* and Maria Monica Gramatges, MD, PhD1,2

1Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
2Department of Pediatrics, Baylor College of Medicine, Houston, TX

Satoshi Nishiwaki1*, Isamu Sugiura2, Shin Fujisawa3*, Yoshihiro Hatta4, Noriko Doki5*, Shingo Kurahashi6*, Yasunori Ueda7, Nobuaki Dobashi8, Tomoya Maeda9*, Yasuhiro Taniguchi10*, Masatsugu Tanaka11*, Shinichi Kako12, Tatsuo Ichinohe13, Takahiro Fukuda14*, Yoshiko Atsuta15,16*, Shigeki Ohtake17, Yuichi Ishikawa18*, Hitoshi Kiyoi19, Itaru Matsumura20 and Yasushi Miyazaki, MD21

1Department of Advanced Medicine, Nagoya University Graduate Sch of Medicine, Nagoya, Japan
2Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan
3Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
4Division of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
5Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
6Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan
7Department of Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan
8Department of Clinical Oncology/Hematology, The Jikei University School of Medicine, Tokyo, Japan
9Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan
10Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, JPN
11Department of Hematology, Kanagawa Cancer Center, Yokohama, KAN, Japan
12Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
13Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan
14Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
15Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
16Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan
17Kanazawa University, Kanazawa, Japan
18Department of Hematology and Oncology, Nagoya Univesity Gradutachool of Medicine, Nagoya, JPN
19Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya-shi, Japan
20Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osakasayama, Japan
21Department of Hematology, Atomic Bomb Disease Institute, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

Christina Egnell Gustafsson, MD1,2*, Grete Götzsche Frederiksen2*, Josefine Thorwaldson2*, Mats Heyman3,4, Arja Harila-Saari, PhD, MD5,6 and Susanna Ranta2,4*

1Karolinska University Hospital, Bromma, Stockholm, Sweden
2Department of Women's and Children's Health, Karolinska institutet, Stockholm, Sweden
3Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
4Karolinska University Hospital, Stockholm, Sweden
5Uppsala University Hospital, Uppsala, Sweden
6Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden

Ravi Kishore Narra, MD, MS1, Ehab L. Atallah, MD2, Laura C. Michaelis, MD3, Karen Carlson, MD, PhD3, Lyndsey Runaas, MD4*, Aniko Szabo, PhD5* and Guru Subramanian Guru Murthy, MD3*

1Medical College of Wisconsin, Brookfield, WI
2Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
3Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
4Medical College of Wisconsin Cancer Center, Milwaukee, WI
5Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI

Keith J August, MD, MS1, Tristan Flatt, DO2*, Joy M. Fulbright, MD2*, Alan S. Gamis, MD, MPH2, Julia A. Hays, MD2*, Maxine J Hetherington, MD2*, Karen Lewing, MD2*, Amanda August, PharmD2* and Erin Guest, MD2

1Chidren's Mercy Hospital, Kansas City, MO
2Children's Mercy Kansas City, Kansas City, MO

Maria Agustina Perusini, MD1, Jad Sibai, MSc2*, Eshetu G. Atenafu, M.Sc., P.Stat3*, Aniket Bankar, MBBS, MD, DM1, Mark D. Minden, MD, PhD1, Vikas Gupta, MD, FRCP, FRCPath1, Dawn Maze, MD, FRCPC, MSc1, Marta B. Davidson, MD, PhD4, Steven M. Chan, MD, PhD4, Aaron D. Schimmer, MD, PhD5, Guillaume Richard-Carpentier, MD, FRCPC1, Josephine Anne Lucero, MD1, Claire Andrews, MB, FRCPath6, Dennis Dong Hwan Kim, MD, PhD2*, Karen Yee, MD1, Andre C. Schuh, MD5 and Hassan Sibai, MBBS, MD7*

1Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
2Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
3Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
4Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Division of Medical Oncology and Hematology, University Health Network, Toronto, ON, Canada
6Haematology, Mater Misericordiae University Hospital, Dublin, Ireland
7Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Karen Heyly Vallejo, Pre Med1*, Quetzali Hernandez, Pre Med2*, Jason Lu, MD3*, Victor Itaí Urbalejo Ceniceros, MD4, Purnima Sravanti Teegavarapu, MD5, Gustavo Rivero, MD5 and Nidia Paulina Zapata, MD6

1Instituto Nacional de Cancerologia, Ciudad de Mexico, DF, Mexico
2Instituto Nacional de Cancerologia, Mexico City, Mexico
3Department of Medicine, Baylor College of Medicine, Houston, TX
4Hematology Department, Instituto Nacional de Cancerología, México, DF, Mexico
5Department of Medicine, Hematology/Oncology, Baylor College of Medicine, Houston, TX
6Instituto Nacional de Cancerología, Mexico, Mexico

Andres Felipe Fajardo, MD1, Stephanie Cox, RN (EC), MN, NP2*, Paula MacDonald, BPharm2*, Sabrina Millson, CCRP2* and Uma H. Athale, MD, MBBS, MSc2

1McMaster Children's Hospital Department of Pediatrics, McMaster University, Hamilton, ON, Canada
2Pediatrics, McMaster University Div. of Pediatric Hematology/Oncology, Hamilton, ON, Canada

Lucas Zarling, MD1*, Philip Stevenson, MS2*, Lorinda A. Soma, MD3,4*, Christen H. Martino, ARNP1,4*, Mary-Elizabeth M. Percival, MD1,4, Anna B. Halpern, MD1,4, Cristina Ghiuzeli, MD1,4, Pamela S. Becker, MD, PhD1,4,5, Vivian Oehler, MD4,6, Jason P. Cooper, MD, PhD1,4, Johnnie J. Orozco, MD, PhD1,4, Paul C. Hendrie, MD, PhD1,4, Roland B. Walter, MD, PhD, MS1,4, Elihu H. Estey, M.D.4,7 and Ryan D. Cassaday, MD1,8

1Department of Medicine, University of Washington, Seattle, WA
2Clinical Statistics Division, Fred Hutchinson Cancer Center, Seattle, WA
3Department of Laboratory Medicine, University of Washington, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
5Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
6Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
7Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
8UW/FHCRC, Seattle, WA

Surabhi Sivaratnam, BHSc, MD in progress1* and Uma H. Athale, MD, MBBS, MSc2

1McMaster University, Hamilton, ON, Canada
2Pediatrics, McMaster University Div. of Pediatric Hematology/Oncology, Hamilton, ON, Canada

Ekrem Turk, MD1*, Khaldun Obeidat1*, Vaishali Deenadayalan, MD1, Rafaella Litvin, MD1*, Amani Erra, MD2, Maryam Zia1 and Shelby D. Rifkin, MD1

1John H Stroger Jr Hospital of Cook County, Chicago, IL
2Division of Hematology/Oncology, John H Stroger Jr. Hospital of Cook County, Chicago, IL

*signifies non-member of ASH